# RADIQAL Study (Radiation Dose and Image Quality Trial)

Study · id `cardio:ct-nct06944509` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06944509](<https://clinicaltrials.gov/study/NCT06944509>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06944509

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 824 participants.

## Technical summary

Registry record NCT06944509. Randomized; no masking; primary purpose other. Start 2025-05-14 (actual); primary completion 2027-03-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose other
- Phase: Not applicable
- Enrolled: 824 participants (planned count; ClinicalTrials.gov record NCT06944509, source copy `cardio:ctgov-nct06944509-2026-06-12`, retrieved 2026-10-26)
- Started: 2025-05-14 (actual) (ClinicalTrials.gov record NCT06944509, source copy `cardio:ctgov-nct06944509-2026-06-12`, retrieved 2026-10-26)
- Primary completion: 2027-03-31 (anticipated) (ClinicalTrials.gov record NCT06944509, source copy `cardio:ctgov-nct06944509-2026-06-12`, retrieved 2026-10-26)
- Completion: 2027-03-31 (anticipated) (ClinicalTrials.gov record NCT06944509, source copy `cardio:ctgov-nct06944509-2026-06-12`, retrieved 2026-10-26)
- Countries: United States; Czechia; Denmark; Spain (ClinicalTrials.gov record NCT06944509, source copy `cardio:ctgov-nct06944509-2026-06-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06944509-2026-06-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: RADIQAL Study (Radiation Dose and Image Quality Trial)
- Acronym: RADIQAL
- Condition: Coronary Artery Disease
- Intervention (Device): treatment with the Azurion system with Xres5
- Intervention (Other): Azurion with Clairy IQ
- Lead sponsor: Philips Clinical & Medical Affairs Global
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Philips Clinical & Medical Affairs Global (`cardio:org-philips-clinical-medical-affairs-global`)

## Provenance

Content hash: fa2993bda0ff4ec71f834001ee44789400ca0d3eccebef871f0668c39fe39bde
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
